GENETIC TECHNOLOGIES LIMITEDGG

GENETIC TECHNOLOGIES LIMITED

0.039AUDD
+0.001+2.63%
At close at Nov 30, 2024, 17:46 GMT
AUD
No trades
See on Supercharts

GTG fundamentals

GENETIC TECHNOLOGIES LIMITED revenue breakdown overview

GENETIC TECHNOLOGIES LIMITED revenue for the last year amounted to 7.66 M AUD, the most of which — 6.16 M AUD — came from its highest performing source at the moment, EasyDNA, the year earlier bringing 7.70 M AUD. The greatest contribution to the revenue figure was made by Europe, Middle East and Africa — last year it brought GENETIC TECHNOLOGIES LIMITED 4.07 M AUD, and the year before that — 4.49 M AUD.

By source
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
‪‪10.00 M‬‬
EasyDNA
AffinityDNA
GeneType/Corporate
Genetic Testing and Risk Assessment Tools
Research
Licensing
Corporate
Biotech
Investment
Currency: AUD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
EasyDNA
‪‪6.00 M‬‬
‪‪7.70 M‬‬
‪‪6.16 M‬‬
AffinityDNA
‪‪944.06 K‬‬
‪‪1.37 M‬‬
GeneType/Corporate
‪‪793.39 K‬‬
‪‪43.45 K‬‬
‪‪134.09 K‬‬
Genetic Testing and Risk Assessment Tools
‪‪9.86 K‬‬
‪‪120.55 K‬‬
Research
Licensing
Corporate
Biotech
Investment
By country
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
‪‪10.00 M‬‬
Europe, Middle East and Africa
Asia Pacific
America and Canada
Latin America
Australia
United States
China
Canada
Switzerland
Currency: AUD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Europe, Middle East and Africa
‪‪2.50 M‬‬
‪‪4.49 M‬‬
‪‪4.07 M‬‬
Asia Pacific
‪‪1.89 M‬‬
‪‪1.63 M‬‬
‪‪1.74 M‬‬
America and Canada
‪‪2.27 M‬‬
‪‪2.24 M‬‬
‪‪1.67 M‬‬
Latin America
‪‪128.84 K‬‬
‪‪322.03 K‬‬
‪‪190.42 K‬‬
Australia
‪‪3.16 K‬‬
‪‪102.42 K‬‬
United States
‪‪6.70 K‬‬
‪‪18.14 K‬‬
China
Canada
Switzerland